This study is a multicenter, open-label, observational, postmarketing surveillance study of Genentech growth hormone (GH) products in the treatment of girls with Turner syndrome in the United States and Canada.
Study Type
OBSERVATIONAL
Enrollment
1,696
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.